Error loading player: No playable sources found

2520

H pylori and Gastric Cancer - Updates in Pathogenesis and Diagnosis

Date
May 18, 2024

SOCIETY: AGA Mechanisms underlying H pylori related gastric pathology

Presentations:

IL-17 SIGNALING REDUCES GASTRIC CARCINOGENESIS BY ALTERING FUNCTION OF THE HELICOBACTER CAG TYPE 4 SECRETION SYSTEM AND SUPPRESSING LRIG1 ACTIVATION
TARGETED IN VIVO COMPETITION AMONG CO-INFECTING HELICOBACTER PYLORI STRAINS INCREASES CAGA-DEPENDENT INFLAMMATION, INJURY, AND CARCINOGENESIS WITHIN THE CONTEXT OF IRON DEFICIENCY
IMPLICATION OF HYPUSINATION IN HELICOBACTER PYLORI-INDUCED GASTRIC CARCINOGENESIS
HELICOBACTER PYLORI ERADICATION AND GASTRIC CANCER RISK IN GASTRIC ULCER PATIENTS: A NATIONWIDE COHORT STUDY
HELICOBACTER PYLORI-INDUCED FERROPTOSIS CONTRIBUTES TO ATROPHIC GASTRITIS VIA MODULATING SELENIUM UTILIZATION BY GPX4.

Moderators

Speaker Image for Steven Moss
Brown University
Speaker Image for John Kao
University of Michigan

Related Products

Thumbnail for FDA Town Hall
FDA Town Hall
SOCIETY: AGA The AGA-FDA Town Hall provides health care professionals, clinical trial investigators, and other interested stakeholders an opportunity to hear directly from FDA representatives about the agency's thinking behind recent approvals, safety signals, guidance documents, and boxed warnings…